GT Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RETIREMENT GROUP, LLC | 04/30/2024 | 1 | $4 | -97.73% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/10/2024 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 05/14/2024 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 05/10/2024 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 10/17/2024 | 0 | $0 | -100.00% | 0.00% |
| BANK OF MONTREAL /CAN/ | 05/13/2024 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/13/2024 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
| BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 04/24/2024 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 05/10/2024 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 04/25/2024 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 05/10/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
| WELCH GROUP, LLC | 04/09/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/13/2024 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/16/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MOSS ADAMS WEALTH ADVISORS LLC | 05/07/2024 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/10/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ATRIA WEALTH SOLUTIONS, INC. | 05/13/2024 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
GT Biopharma, Inc. institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of GT Biopharma, Inc.. The most heavily invested institutionals were:
Retirement Group, LLC: 1
TimeScale Financial, Inc.: 549
American Portfolios Advisors: 14
Cordasco Financial Network: 0
Amalgamated Financial Corp.: 2,959
0.00% of GT Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3,523 shares in the last 24 months. This purchase volume represents approximately $10,534 in transactions.